Hematogenix
Aina Farhana Zulkipli is a Project Manager at Hematogenix since March 2022, with previous experience as an Associate Alliance Manager and Patient Recruitment Specialist at Clinical Research Malaysia from October 2018 to March 2022. Prior to that, Aina worked as a Research Officer at the University of Malaya, focusing on drug discovery and development challenges in Malaysia from July 2017 to September 2018. Aina's earlier experience includes roles as a Research Consultant at BCI Asia in mid-2016 and a Research Assistant at the University of Malaya between July 2012 and June 2016, participating in the Malaysian Breast Cancer Cohort Study and engaging in data management and analysis. Aina holds a Master of Medical Science in Public Health from the University of Malaya and a Degree in Biomedical Science from the International Islamic University Malaysia.
This person is not in any offices
Hematogenix
1 followers
Hematogenix, a global cancer-focused life science company serving the pharmaceutical & biotechnology industry as well as community physicians. With passionate scientists and board-certified clinical and anatomic pathologists and hematopathologists from around the world, Hematogenix offers an array of biomarker development and testing services navigating the complexities of human diseases and clinical trials. Our global team of scientists provides reference laboratory services at our facilities around the globe: in the US, Europe, China, and Asia-Pacific. We are uniquely equipped to help clients accelerate cancer research and drug development efforts at these globally connected facilities. Hematogenix provides a complete menu of services such as Flow Cytometry, Molecular Genetics, Next Generation Sequencing (NGS), Histology / Immunohistochemistry (IHC), Cytogenetics / FISH, Pathology, Digital Pathology and Image Analysis. Our test menu reflects our commitment to utilizing the most advanced techniques to enhance patient care. We provide customized services ranging from the initial stages of research to development, and extending all the way to the implementation of targeted therapies in the clinical setting. * CAP – Accredited * CLIA – Certified * GCP – Compliant